What are the characteristics of Addison's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Addison's Disease

Addison's disease is a rare endocrine disorder characterized by inadequate production of cortisol and aldosterone due to damage to the adrenal cortex, with a prevalence of 10-15 per 100,000 population, primarily presenting with fatigue, hyperpigmentation, hypotension, and electrolyte disturbances. 1

Definition and Pathophysiology

  • Addison's disease (primary adrenal insufficiency) results from damage to the adrenal cortex leading to inadequate production of cortisol and aldosterone 1
  • In Europe, autoimmunity is the predominant cause (approximately 85% of cases), with other causes including tuberculosis, adrenal hemorrhage, and genetic disorders 1
  • The main autoimmune mechanism involves destruction of adrenal cortical cells by an autoreactive process directed against the steroid-synthesizing enzyme 21-hydroxylase 2

Clinical Presentation

Common Symptoms

  • Symptoms develop insidiously over months to years and include: 3, 1
    • Fatigue and weakness
    • Unintentional weight loss
    • Anorexia
    • Salt craving
    • Nausea and vomiting
    • Abdominal pain
    • Muscle and joint pain

Physical Signs

  • Hyperpigmentation of the skin, especially in sun-exposed areas, palmar creases, frictional surfaces, vermilion border, recent scars, genital skin, and oral mucosa 4, 5
  • Hypotension, often orthostatic 3
  • Vitiligo and other signs of autoimmune disease may be present 1

Laboratory Findings

  • Hyponatremia (present in 90% of newly diagnosed cases) 3, 1
  • Hyperkalaemia (in approximately 50% of cases) 3, 1
  • Low serum cortisol and high plasma ACTH levels 3
  • Increased plasma renin activity with low serum aldosterone 3
  • Mild to moderate hypercalcemia may be present in 10-20% of patients 3
  • Mild eosinophilia, lymphocytosis, and increased liver transaminases may be observed 3
  • Children, but rarely adults, may present with hypoglycemia 3

Diagnosis

  • The diagnosis follows a two-step approach: first assessing adrenal cortex function, then establishing etiology 3, 1
  • Paired measurement of serum cortisol and plasma ACTH is the initial diagnostic test 1
  • Serum cortisol <250 nmol/L with elevated ACTH during acute illness is diagnostic of primary adrenal insufficiency 3, 1
  • In equivocal cases, a synacthen (tetracosactide) stimulation test is performed (0.25 mg IM or IV), with peak serum cortisol <500 nmol/L confirming the diagnosis 3, 1
  • Treatment of suspected acute adrenal insufficiency should never be delayed by diagnostic procedures 3

Etiology

  • The etiology should be determined starting with measurement of 21-hydroxylase (anti-adrenal) autoantibodies 3
  • If antibodies are negative, CT imaging of the adrenal glands is recommended to demonstrate tumors or calcifications typical of tuberculosis 3
  • Males should be screened for adrenoleukodystrophy by measuring very long-chain fatty acids 3
  • Autoimmune polyendocrine syndrome type-1 (APS-1) should be considered in children and young persons presenting with PAI and other manifestations (e.g., hypoparathyroidism and candidiasis) 3, 1

Associated Conditions

  • Approximately half of patients with autoimmune PAI have other co-existing autoimmune diseases 1
  • These combinations are classified into polyendocrine syndromes: 1
    • Autoimmune polyendocrine syndrome type-1 (APS-1): PAI, hypoparathyroidism, and chronic mucocutaneous candidiasis
    • Autoimmune polyendocrine syndrome type-2 (APS-2): PAI with primary hypothyroidism and other autoimmune conditions

Treatment

  • Patients require lifelong hormone replacement therapy with both glucocorticoids and mineralocorticoids 3, 1
  • Hydrocortisone (HC) or cortisone acetate (CA) are the preferred glucocorticoids, taken in 2-3 divided doses 3, 6
  • Typical dosing: HC 15-25 mg per day or CA 20-30 mg per day, with the largest dose in the morning 1, 6
  • Fludrocortisone is used for mineralocorticoid replacement 7
  • Increased sodium chloride intake is often needed to compensate for renal loss 3
  • Dosage adjustment is based on clinical assessment rather than laboratory values 3, 6
  • Signs of over-replacement include weight gain, insomnia, and peripheral edema 3, 6
  • Signs of under-replacement include lethargy, nausea, poor appetite, weight loss, and increased pigmentation 3, 6

Management of Adrenal Crisis

  • Adrenal crisis is a life-threatening emergency requiring immediate treatment 1, 6
  • Treatment includes immediate administration of hydrocortisone 100 mg IV or IM, followed by 100 mg every 6-8 hours until recovery 1, 2
  • Rapid infusion of isotonic (0.9%) sodium chloride solution is essential 1

Patient Education and Follow-up

  • All patients should wear a Medic Alert bracelet and carry a steroid card 3, 1, 6
  • Education on increasing steroid doses during illness or injury is essential 3, 1
  • Annual follow-up should include assessment of well-being, weight, blood pressure, serum electrolytes, and screening for development of new autoimmune disorders 1, 6

Prognosis

  • With proper treatment, Addison's disease is a manageable chronic condition 1
  • However, premature death from adrenal crises remains a risk without proper management 1
  • Neuropsychiatric manifestations including depression and psychosis can occur and impact quality of life 8

References

Guideline

Addison's Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Autoimmune adrenal insufficiency: recognition and management.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Addison's disease.

Clinics in dermatology, 2006

Guideline

Treatment of Adrenal Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Replacement therapy in Addison's disease.

Expert opinion on pharmacotherapy, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.